BRIA Capital Group, LLC’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.41M Buy
2,082
+368
+21% +$434K 1.64% 14
2026
Q2
$2.06M Buy
1,714
+562
+49% +$574K 1.52% 17
2026
Q1
$1.06M Buy
1,152
+4
+0.3% +$4.06K 0.96% 25
2025
Q4
$1.23M Buy
+1,148
New +$1.1M 1.13% 27

Other funds holding LLY

BRIA Capital Group, LLC's LLY Position: Q3 2026 in Review

BRIA Capital Group, LLC increased its Eli Lilly (LLY) stake by 21% in Q3 2026, buying an estimated $434K and bringing the position to 2,082 shares worth $2.41M. The position accounts for 1.64% of the portfolio, ranked #14.

BRIA Capital Group, LLC first reported a position in LLY in Q4 2025 and has held it in 4 quarters since. 1,387 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • BRIA Capital Group, LLC held 2,082 shares of Eli Lilly worth $2.41M as of Q3 2026.
  • BRIA Capital Group, LLC bought 368 Eli Lilly shares in Q3 2026, an estimated $434K.
  • Eli Lilly made up 1.64% of BRIA Capital Group, LLC's portfolio in Q3 2026, its #14 holding.
  • BRIA Capital Group, LLC first reported a position in Eli Lilly in Q4 2025 and has held it in 4 quarters since.
  • 1,387 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on BRIA Capital Group, LLC's 13F filing for Q3 2026, filed 22 Oct 2026.